Almutairi AR - Search Results

1

Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis.

Alkhushaym N, Almutairi AR, Althagafi A, Fallatah SB, Oh M, Martin JR, Babiker HM, McBride A, Abraham I. Alkhushaym N, et al. Among authors: almutairi ar. Expert Opin Drug Saf. 2020 Mar;19(3):327-334. doi: 10.1080/14740338.2020.1715939. Epub 2020 Jan 21. Expert Opin Drug Saf. 2020. PMID: 31928106

2

Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.

Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, Lo-Ciganic WH. Almutairi AR, et al. Clin Ther. 2017 Jul;39(7):1456-1478.e36. doi: 10.1016/j.clinthera.2017.05.358. Epub 2017 Jun 28. Clin Ther. 2017. PMID: 28668628 Review.

3

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma.

Almutairi AR, Alkhatib NS, Oh M, Curiel-Lewandrowski C, Babiker HM, Cranmer LD, McBride A, Abraham I. Almutairi AR, et al. JAMA Dermatol. 2019 Jan 1;155(1):22-28. doi: 10.1001/jamadermatol.2018.3958. JAMA Dermatol. 2019. PMID: 30477000 Free PMC article. Clinical Trial.

4

The Importance of Outcome and Precise Evaluation in Economic Analysis of Cancer Drugs-Reply.

Almutairi AR, Alkhatib NS, Abraham I. Almutairi AR, et al. JAMA Dermatol. 2019 Jul 1;155(7):863. doi: 10.1001/jamadermatol.2019.0135. JAMA Dermatol. 2019. PMID: 31066865 No abstract available.

5

Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis.

Almutairi AR, Alkhatib N, Martin J, Babiker HM, Garland LL, McBride A, Abraham I. Almutairi AR, et al. Crit Rev Oncol Hematol. 2019 Oct;142:16-25. doi: 10.1016/j.critrevonc.2019.07.004. Epub 2019 Jul 10. Crit Rev Oncol Hematol. 2019. PMID: 31326706

6

Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials.

Alhifany AA, Almutairi AR, Almangour TA, Shahbar AN, Abraham I, Alessa M, Alnezary FS, Cheema E. Alhifany AA, et al. Among authors: almutairi ar. BMJ Open. 2019 Nov 7;9(11):e031145. doi: 10.1136/bmjopen-2019-031145. BMJ Open. 2019. PMID: 31699731 Free PMC article.

7

Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis.

Alhifany AA, McBride A, Almutairi AR, Cheema E, Shahbar A, Alatawi Y, Alharbi AS, Babiker H, MacDonald K, Aapro M, Abraham I. Alhifany AA, et al. Among authors: almutairi ar. Support Care Cancer. 2020 Mar;28(3):1031-1039. doi: 10.1007/s00520-019-05210-4. Epub 2019 Dec 10. Support Care Cancer. 2020. PMID: 31823054

8

Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis.

Almutairi AR, McBride A, Slack M, Erstad BL, Abraham I. Almutairi AR, et al. Front Oncol. 2020 Feb 11;10:91. doi: 10.3389/fonc.2020.00091. eCollection 2020. Front Oncol. 2020. PMID: 32117745 Free PMC article.

9

Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.

Oh M, Patanwala AE, Alkhatib N, Almutairi A, Abraham I, Erstad B. Oh M, et al. Crit Care Med. 2020 Oct;48(10):e906-e911. doi: 10.1097/CCM.0000000000004501. Crit Care Med. 2020. PMID: 32701552

10

Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data.

Almutairi AR, Erstad BL, McBride A, Slack M, Abraham I. Almutairi AR, et al. Expert Opin Drug Saf. 2021 Apr;20(4):489-497. doi: 10.1080/14740338.2021.1877272. Epub 2021 Jan 25. Expert Opin Drug Saf. 2021. PMID: 33445985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page